Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells-Reference-Cited by-同舟云学术

Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells

Published:2020-02 Issue:2 Volume:522 Page:402-407
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kim Dong Jun,Jang Ji Hun,Ham Soo-Youn,Choi Seong Hee,Park Sung Soon,Jeong So Yeon,Kim Beom Chang,Jeon Do Yong,Lee Byung Ju,Ko Byung Kyun,Park Jeong Woo,Cho Wha Ja

Funder

National Research Foundation of Korea

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. The diverse functions of the PD1 inhibitory pathway;Sharpe;Nat. Rev. Immunol.,2018

2. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat. Med.,2002

3. The future of immune checkpoint therapy;Sharma;Science,2015

4. MYC regulates the antitumor immune response through CD47 and PD-L1;Casey;Science,2016

5. A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma;Wang;Hum. Genet.,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress granules in cancer: Adaptive dynamics and therapeutic implications;iScience;2024-08

2. PD-L1 at the crossroad between RNA metabolism and immunosuppression;Trends in Molecular Medicine;2024-07

3. Doxorubicin affects expression of the ZFP36 and CTTN genes in MCF7 cell line;Biopolymers and Cell;2024-06-18

4. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06

5. Impact of Chemotherapeutic Agents on PD-L1, CTLA-4, and VISTA Gene Expression in Cervical Cancer Cell Lines: An In Vitro Study;Indian Journal of Gynecologic Oncology;2024-04-29